Rui Fernandes

Rui Fernandes

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2001 in The American Journal of Pathology
Verified
Journal Article
Closed access
Monica SousaMonica Sousa
Monica Sousa
ICIsabel Cardoso
Isabel Cardoso
RFRui Fernandes
Rui Fernandes
AGAntónio Guimarães
António Guimarães
MSMaria João Saraiva
Maria João Saraiva

1 September 2007 in Biomaterials
Verified
Journal Article
Closed access
MEMarta B. Evangelista
Marta B. Evangelista
SHSusan X. Hsiong
Susan X. Hsiong
RFRui Fernandes
Rui Fernandes
PSPaula Sampaio
Paula Sampaio
HKHyun-Joon Kong
Hyun-Joon Kong
Pedro GranjaPedro Granja
Pedro Granja

1 February 2016 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
ANAna Rute Neves
Ana Rute Neves
JQJoana Fontes Queiroz
Joana Fontes Queiroz
Sofia LimaSofia Lima
Sofia Lima
FFFrancisco Figueiredo
Francisco Figueiredo
RFRui Fernandes
Rui Fernandes
Salette ReisSalette Reis
Salette Reis

1 June 2000 in The American Journal of Pathology
Verified
Journal Article
Closed access
Monica SousaMonica Sousa
Monica Sousa
CVClaude Vital
Claude Vital
DODominique Ostler
Dominique Ostler
RFRui Fernandes
Rui Fernandes
JPJean Pouget-Abadie
Jean Pouget-Abadie
MSMaria Joao Saraiva
Maria Joao Saraiva

1 November 2002 in The American Journal of Pathology
Verified
Journal Article
Closed access
Monica SousaMonica Sousa
Monica Sousa
RFRui Fernandes
Rui Fernandes
JPJoana Almeida Palha
Joana Almeida Palha
ATAna Taboada
Ana Taboada
PVPaulo Vieira
Paulo Vieira
MSMaria Joao Saraiva
Maria Joao Saraiva

17 December 2015 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
ÂIÂngela Inácio
Ângela Inácio
NDNeuza S. Domingues
Neuza S. Domingues
ANAlexandra Nunes
Alexandra Nunes
PMPatrícia T. Martins
Patrícia T. Martins
Maria João MorenoMaria João Moreno
Maria João Moreno
Otilia VieiraOtilia Vieira
Otilia Vieira
Broad-spectrum antimicrobial activity of quaternary ammonium surfactants (QAS) makes them attractive and cheap topical prophylactic options for sexually transmitted infections and perinatal vertically transmitted urogenital infections. Although attributed to their high affinity for biological membranes, the mechanisms behind QAS microbicidal activity are not fully understood. We evaluated how QAS structure affects antimicrobial activity and whether this can be exploited for use in prophylaxis of bacterial infections. Acute toxicity of QAS to in vitro models of human epithelial cells and bacteria were compared to identify selective and potent bactericidal agents. Bacterial cell viability, membrane integrity, cell cycle and metabolism were evaluated to establish the mechanisms involved in selective toxicity of QAS. QAS toxicity normalized relative to surfactant critical micelle concentration showed n-dodecylpyridinium bromide (C12PB) to be the most effective, with a therapeutic index of ∼10 for an MDR strain of Escherichia coli and >20 for Neisseria gonorrhoeae after 1 h of exposure. Three modes of QAS antibacterial action were identified: impairment of bacterial energetics and cell division at low concentrations; membrane permeabilization and electron transport inhibition at intermediate doses; and disruption of bacterial membranes and cell lysis at concentrations close to the critical micelle concentration. In contrast, toxicity to mammalian cells occurs at higher concentrations and, as we previously reported, results primarily from mitochondrial dysfunction and apoptotic cell death. Our data show that short chain (C12) n-alkyl pyridinium bromides have a sufficiently large therapeutic window to be good microbicide candidates.